Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


POLARstar Optima Multimode Plate Reader with FP

Product Description
polarstar-optima.jpg

The POLARstar OPTIMA is a full multimode microplate reader which incorporates Simultaneous Dual Emission detection for fluorescent polarization. The POLARstar OPTIMA offers five different measurement principles:

• Fluorescence Polarization
• Fluorescence Intensity - including FRET
• Time-Resolved Fluorescence - including DELFIA®
• High-Performance Luminescence (flash and glow)- including BRET
• Absorbance - UV/Vis with path length correction

The POLARstar OPTIMA is designed for the widest possible range of non-radioactive labeled applications:

• Ca2+ Measurements (e.g. Ca2+Flux with Fura-2 or Indo-1)
• Molecular Interactions
• Enzyme Activity
• Cell Toxicity, Proliferation and Viability
• ATP Quantification
• Immunoassays
• Kinase, cAMP, and other second messenger signaling
• DNA/RNA quantification
• GFP and other fluorescent protein cell-based assays
• And many more…

The POLARstar OPTIMA is a multimode microplate reader that covers the wavelength range from 240 – 740 nm (900 nm optional). The POLARstar OPTIMA reads all plate formats from 6- up to 384-well. Top and bottom reading are standard, and the dual-channel detection system can be used for fluorescence polarization as well as dual emission wavelength measurements like FRET or BRET. Incubation up to 45°C or 60°C, gas vent connection, up to two built-in reagent injectors, fast filter wheels, and the ability to define up to 8 sets of filters are just some of the outstanding features found in the POLARstar OPTIMA.

Complete Software Package
The POLARstar OPTIMA comes with BMG LABTECH's established OPTIMA Reader Control Software and comprehensive MARS Data Analysis Software. The familiar and highly visual OPTIMA reader control software provides limitless possibilities for test set up and is fully compliant with FDA regulation 21 CFR Part 11. The well-organized Data Analysis Software – MARS – offers a Template Manager for building complex data processing protocols and a Wizard-guided interface to create easy step-by-step calculations, and much more.
Product POLARstar Optima Multimode Plate Reader with FP
Company BMG Labtech GmbH
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

BMG Labtech GmbH
Allmendgruen 8, 77799 Ortenberg Germany

Tel: +49 781 96968-0
Fax: +49 781 96968-67
Email: hts@bmglabtech.com



Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
72% Rise in Metastatic Prostate Cancer
Over the 2003-2013 period metastatic cancer has increased by an average of 72%, this could be caused by lax screening, more aggressive disease or both.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
Scientists Link Bipolar Disorder to Unexpected Brain Region
Researchers from The Scripps Research Institute have found that gene within the brain’s striatum could be linked to biopolar disorder.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Accessing Metabolic Information with Mass Spec
Scientists at the Helmholtz Zentrum München have developed a new mass spectrometry imaging method which, for the first time, makes it possible to analyze hundreds of metabolites in fixed tissue samples.
Zika Epidemic Likely to End Within Three Years
A team of scientists has predicted that the current Zika epidemic is likely to end within three years because there will be too few people left to infect.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!